论文部分内容阅读
目的对治疗肾盂肾炎患者应用头孢哌酮联合舒巴坦的效果进行探究。方法 100例肾盂肾炎患者,随机分为对照组与观察组,各50例。对照组使用左氧氟沙星治疗,观察组使用头孢哌酮联合舒巴坦治疗。对两组患者的不良反应发生情况以及临床疗效进行研究与分析。结果观察组的治疗有效率为88.00%,与对照组的40.00%相比有显著提高,两组治疗有效率比较差异具有统计学意义(P<0.05)。观察组的不良反应发生率为32.00%,与对照组的72.00%比较有显著降低,两组不良反应发生率比较差异具有统计学意义(P<0.05)。结论采取头孢哌酮联合舒巴坦治疗肾盂肾炎,在保障患者不良反应率较低的条件下,可有效地提高其疗效,效果很显著,值得医疗界的推广及其应用。
Objective To investigate the effect of cefoperazone combined with sulbactam on patients with pyelonephritis. Methods 100 cases of pyelonephritis patients were randomly divided into control group and observation group, 50 cases each. The control group was treated with levofloxacin and the observation group was treated with cefoperazone and sulbactam. The two groups of patients with adverse reactions and clinical efficacy of research and analysis. Results The effective rate of treatment in the observation group was 88.00%, which was significantly higher than that in the control group (40.00%). There was significant difference between the two groups in the treatment efficiency (P <0.05). The incidence of adverse reactions in the observation group was 32.00%, which was significantly lower than that in the control group (72.00%). The incidence of adverse reactions in the two groups was statistically significant (P <0.05). Conclusions Cefoperazone combined with sulbactam in the treatment of pyelonephritis, under the condition of ensuring the patients with low adverse reaction rate, can effectively improve the curative effect, and the effect is significant. It is worthy of popularization and its application in the medical community.